These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 27569939

  • 1. Anti-vimentin Antibodies Present at the Time of Transplantation May Predict Early Development of Interstitial Fibrosis/Tubular Atrophy.
    Lopez-Soler RI, Borgia JA, Kanangat S, Fhied CL, Conti DJ, Constantino D, Ata A, Chan R, Wang Z.
    Transplant Proc; 2016; 48(6):2023-33. PubMed ID: 27569939
    [Abstract] [Full Text] [Related]

  • 2. Role of anti-vimentin antibodies in renal transplantation.
    Besarani D, Cerundolo L, Smith JD, Procter J, Barnardo MC, Roberts IS, Friend PJ, Rose ML, Fuggle SV.
    Transplantation; 2014 Jul 15; 98(1):72-8. PubMed ID: 24978037
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Altered Expression of MicroRNAs Following Chronic Allograft Dysfunction with Interstitial Fibrosis and Tubular Atrophy.
    Soltaninejad E, Nicknam MH, Nafar M, Sharbafi MH, Keshavarz Shahbaz S, Barabadi M, Yekaninejad MS, Bahrami T, Ahmadpoor P, Amirzargar A.
    Iran J Allergy Asthma Immunol; 2015 Dec 15; 14(6):615-23. PubMed ID: 26725559
    [Abstract] [Full Text] [Related]

  • 7. Immunoglobulin isotype switching of antibodies to vimentin is associated with development of transplant glomerulopathy following human renal transplantation.
    Gunasekaran M, Maw TT, Santos RD, Shenoy S, Wellen J, Mohanakumar T.
    Transpl Immunol; 2017 Dec 15; 45():42-47. PubMed ID: 28911876
    [Abstract] [Full Text] [Related]

  • 8. Inflammation in Early Kidney Allograft Surveillance Biopsies With and Without Associated Tubulointerstitial Chronic Damage as a Predictor of Fibrosis Progression and Development of De Novo Donor Specific Antibodies.
    García-Carro C, Dörje C, Åsberg A, Midtvedt K, Scott H, Reinholt FP, Holdaas H, Seron D, Reisæter AV.
    Transplantation; 2017 Jun 15; 101(6):1410-1415. PubMed ID: 27163535
    [Abstract] [Full Text] [Related]

  • 9. The causes, significance and consequences of inflammatory fibrosis in kidney transplantation: The Banff i-IFTA lesion.
    Nankivell BJ, Shingde M, Keung KL, Fung CL, Borrows RJ, O'Connell PJ, Chapman JR.
    Am J Transplant; 2018 Feb 15; 18(2):364-376. PubMed ID: 29194971
    [Abstract] [Full Text] [Related]

  • 10. High tacrolimus clearance - a risk factor for development of interstitial fibrosis and tubular atrophy in the transplanted kidney: a retrospective single-center cohort study.
    Egeland EJ, Reisaeter AV, Robertsen I, Midtvedt K, Strøm EH, Holdaas H, Hartmann A, Åsberg A.
    Transpl Int; 2019 Mar 15; 32(3):257-269. PubMed ID: 30252957
    [Abstract] [Full Text] [Related]

  • 11. Lower Circulating Cytotoxic T-Cell Frequency and Higher Intragraft Granzyme-B Expression Are Associated with Inflammatory Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Recipients.
    Yadav B, Prasad N, Agrawal V, Agarwal V, Jain M.
    Medicina (Kaunas); 2023 Jun 20; 59(6):. PubMed ID: 37374379
    [Abstract] [Full Text] [Related]

  • 12. Expression of bone morphogenetic proteins 4, 6 and 7 is downregulated in kidney allografts with interstitial fibrosis and tubular atrophy.
    Furic-Cunko V, Kes P, Coric M, Hudolin T, Kastelan Z, Basic-Jukic N.
    Int Urol Nephrol; 2015 Jul 20; 47(7):1219-29. PubMed ID: 25962604
    [Abstract] [Full Text] [Related]

  • 13. Association of baseline histopathology and kidney donor risk index with graft outcomes in deceased donor kidney transplantation
.
    Park KS, Park SJ, Park H, Kim M, Park J, Chung HC, Cho HR, Lee JS.
    Clin Nephrol; 2019 Jun 20; 91(6):363-369. PubMed ID: 30848240
    [Abstract] [Full Text] [Related]

  • 14. Clinical and pathological analyses of interstitial fibrosis and tubular atrophy cases after kidney transplantation.
    Shimizu T, Toma H, Hayakawa N, Shibahara R, Ishiyama R, Hayashida A, Fujimori D, Tsunoyama K, Ikezawa E, Kitajima S, Iida S, Ishida H, Tanabe K, Honda K, Koike J.
    Nephrology (Carlton); 2016 Jul 20; 21 Suppl 1():26-30. PubMed ID: 26972969
    [Abstract] [Full Text] [Related]

  • 15. Dysregulation of urinary miR-21 and miR-200b associated with interstitial fibrosis and tubular atrophy (IFTA) in renal transplant recipients.
    Zununi Vahed S, Omidi Y, Ardalan M, Samadi N.
    Clin Biochem; 2017 Jan 20; 50(1-2):32-39. PubMed ID: 27521993
    [Abstract] [Full Text] [Related]

  • 16. Impact of recurrent glomerulonephritis on renal graft survival.
    Toledo K, Pérez-Sáez MJ, Navarro MD, Ortega R, Redondo MD, Agüera ML, Rodríguez-Benot A, Aljama P.
    Transplant Proc; 2011 Jan 20; 43(6):2182-6. PubMed ID: 21839228
    [Abstract] [Full Text] [Related]

  • 17. Transplant glomerulopathy: clinical course and factors relating to graft survival.
    López Jiménez V, Fuentes L, Jiménez T, León M, Garcia I, Sola E, Cabello M, Gutierrez C, Burgos D, Ruiz P, Hernandez D.
    Transplant Proc; 2012 Nov 20; 44(9):2599-600. PubMed ID: 23146467
    [Abstract] [Full Text] [Related]

  • 18. Early urinary CCL2 is associated with the later development of interstitial fibrosis and tubular atrophy in renal allografts.
    Ho J, Rush DN, Gibson IW, Karpinski M, Storsley L, Bestland J, Stefura W, HayGlass KT, Nickerson PW.
    Transplantation; 2010 Aug 27; 90(4):394-400. PubMed ID: 20625355
    [Abstract] [Full Text] [Related]

  • 19. Early Antibody-Mediated Kidney Transplant Rejection Associated With Anti-Vimentin Antibodies: A Case Report.
    Rampersad C, Shaw J, Gibson IW, Wiebe C, Rush DN, Nickerson PW, Ho J.
    Am J Kidney Dis; 2020 Jan 27; 75(1):138-143. PubMed ID: 31515140
    [Abstract] [Full Text] [Related]

  • 20. MicroRNA regulation in blood cells of renal transplanted patients with interstitial fibrosis/tubular atrophy and antibody-mediated rejection.
    Matz M, Heinrich F, Lorkowski C, Wu K, Klotsche J, Zhang Q, Lachmann N, Durek P, Budde K, Mashreghi MF.
    PLoS One; 2018 Jan 27; 13(8):e0201925. PubMed ID: 30102719
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.